Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-01

Clinical Trial Update: Effectiveness of Adductor Canal Block Using Liposomal Bupivacaine [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effectiveness of adductor canal block with liposomal bupivacaine for postoperative pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: The University of Hong Kong | Conditions: Pain, Postoperative | Phase 4 | Status: NOT_YET_RECRUITING